Galanin and its receptors: introduction to the Third International Symposium, San Diego, California, USA, 21-22 October 2004.
The Third Galanin Symposium presented many different and exciting results on galanin research reflecting a major progress since the previous symposium in 1998. A major impression was the many possible relationships of galaninergic mechanisms to important brain functions such as development, cognition and ageing as well as many aspects related to a wide spectrum of diseases, including Alzheimer's disease, anxiety/depression, addiction, obesity, pain and tumour growth. These studies were based on an extensive armament of methodologies including various strains of transgenic mice. Unfortunately, the pharmaceutical industry had only a minor participation. Nevertheless, exciting developments in the generation of agonists and antagonists are emerging, providing hope that we at the next symposium will be able to validitate many of the challenging hypotheses concerning galanin and disease with the help of pharmacological tools.
Hökfelt
Tomas
T
Department of Neuroscience, Karolinska Institutet, Retzius väg 8, S-171 77 Stockholm, Sweden. tomas.hokfelt@neuro.ki.se
D000818:Animals; D001927:Brain Diseases / Q000503:physiopathology*; D019004:Galanin / Q000502:physiology*; D006801:Humans; D044088:Receptors, Galanin / Q000502:physiology*
D044088:Receptors, Galanin; D019004:Galanin